The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis.
暂无分享,去创建一个
[1] Saira,et al. Comparison of four serological methods and two RT-PCR assays for diagnosis and surveillance of Zika , 2018 .
[2] P. Vidalain,et al. A Global Interactome Map of the Dengue Virus NS1 Identifies Virus Restriction and Dependency Host Factors. , 2017, Cell reports.
[3] M. Halloran,et al. Antibody-dependent enhancement of severe dengue disease in humans , 2017, Science.
[4] E. Harris,et al. Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components , 2017, PLoS pathogens.
[5] Shuying Wang,et al. Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection , 2017, The Journal of Immunology.
[6] C. King,et al. Generation and Characterization of Antinonstructural Protein 1 Monoclonal Antibodies and Development of Diagnostics for Dengue Virus Serotype 2. , 2017, The American journal of tropical medicine and hygiene.
[7] Daniel Olson,et al. Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum , 2017, Science Translational Medicine.
[8] Yee‐Shin Lin,et al. Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection , 2017, Scientific Reports.
[9] Lourdes Millán-Pérez Peña,et al. IL-10 and socs3 Are Predictive Biomarkers of Dengue Hemorrhagic Fever , 2017, Mediators of inflammation.
[10] F. Rovida,et al. Antibody-based assay discriminates Zika virus infection from other flaviviruses , 2017, Proceedings of the National Academy of Sciences.
[11] Vianney Tricou,et al. Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study. , 2017, The Lancet. Infectious diseases.
[12] Karthik Gangavarapu,et al. Genome sequencing reveals Zika virus diversity and spread in the Americas , 2017, bioRxiv.
[13] T. Hertz,et al. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections , 2017, The Journal of Immunology.
[14] K. Stacey,et al. Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6 , 2017, Immunology and cell biology.
[15] T. Yeo,et al. Increased Serum Hyaluronic Acid and Heparan Sulfate in Dengue Fever: Association with Plasma Leakage and Disease Severity , 2017, Scientific Reports.
[16] R. T. Sasmono,et al. Association of Endothelial Glycocalyx and Tight and Adherens Junctions With Severity of Plasma Leakage in Dengue Infection , 2017, The Journal of infectious diseases.
[17] Catharine I Paules,et al. Yellow Fever - Once Again on the Radar Screen in the Americas. , 2017, The New England journal of medicine.
[18] Yee‐Shin Lin,et al. Antibodies against nonstructural protein 1 protect mice from dengue virus-induced mast cell activation , 2017, Laboratory Investigation.
[19] S. Bhattacharyya,et al. Platelet activation determines the severity of thrombocytopenia in dengue infection , 2017, Scientific Reports.
[20] S. Mallal,et al. Human CD4+ T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity , 2016, Journal of Virology.
[21] M. Diamond,et al. Secreted NS1 Protects Dengue Virus from Mannose-Binding Lectin–Mediated Neutralization , 2016, The Journal of Immunology.
[22] S. Halstead. Licensed Dengue Vaccine: Public Health Conundrum and Scientific Challenge , 2016, The American journal of tropical medicine and hygiene.
[23] S. Kabra,et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India , 2016, Journal of Virology.
[24] F. Scholle,et al. Dengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells. , 2016, Virology.
[25] G. Gao,et al. Contribution of intertwined loop to membrane association revealed by Zika virus full‐length NS1 structure , 2016, The EMBO journal.
[26] R. Mohana-Borges,et al. Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through Interaction with Vitronectin and Terminal Complement Proteins , 2016, Journal of Virology.
[27] J. Stanaway,et al. The global economic burden of dengue: a systematic analysis. , 2016, The Lancet. Infectious diseases.
[28] E. Harris,et al. Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability , 2016, PLoS pathogens.
[29] Yee‐Shin Lin,et al. Dengue Virus Nonstructural Protein 1 Induces Vascular Leakage through Macrophage Migration Inhibitory Factor and Autophagy , 2016, PLoS neglected tropical diseases.
[30] J. Wrammert,et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus , 2016, Proceedings of the National Academy of Sciences.
[31] L. Kramer,et al. Mosquito Saliva Increases Endothelial Permeability in the Skin, Immune Cell Migration, and Dengue Pathogenesis during Antibody-Dependent Enhancement , 2016, PLoS pathogens.
[32] Penghua Wang,et al. Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes , 2016, Nature Microbiology.
[33] Yi Shi,et al. Zika virus NS1 structure reveals diversity of electrostatic surfaces among flaviviruses , 2016, Nature Structural &Molecular Biology.
[34] G. Ogg,et al. Dengue NS1 antigen contributes to disease severity by inducing interleukin (IL)‐10 by monocytes , 2015, Clinical and experimental immunology.
[35] S. M. Costa,et al. Cooperation between CD4+ T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 Antigen , 2015, PLoS neglected tropical diseases.
[36] R. Bartenschlager,et al. Dengue Virus Non-structural Protein 1 Modulates Infectious Particle Production via Interaction with the Structural Proteins , 2015, PLoS pathogens.
[37] Nicholas Jackson,et al. Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. , 2015, The New England journal of medicine.
[38] D. Hume,et al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity , 2015, Science Translational Medicine.
[39] Eva Harris,et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination , 2015, Science Translational Medicine.
[40] S. A. de Oliveira,et al. Circulating cytokines and chemokines associated with plasma leakage and hepatic dysfunction in Brazilian children with dengue fever. , 2015, Acta tropica.
[41] Luis Carrasco,et al. Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin , 2015, Viruses.
[42] E. Pryzdial,et al. Dengue virus binding and replication by platelets. , 2015, Blood.
[43] J. Chu,et al. Activation of TLR2 and TLR6 by Dengue NS1 Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection , 2015, PLoS pathogens.
[44] A. S. St. John,et al. Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcγ receptors , 2015, eLife.
[45] Dominic Waithe,et al. Platelet Activating Factor Contributes to Vascular Leak in Acute Dengue Infection , 2015, PLoS neglected tropical diseases.
[46] V. Volchkov,et al. Shed GP of Ebola Virus Triggers Immune Activation and Increased Vascular Permeability , 2014, PLoS pathogens.
[47] G. Ogg,et al. Dengue NS1 antigen as a marker of severe clinical disease , 2014, BMC Infectious Diseases.
[48] Bjoern Peters,et al. The Human CD8+ T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes , 2014, Journal of Virology.
[49] H. Margolis,et al. Evaluation of Commercially Available Diagnostic Tests for the Detection of Dengue Virus NS1 Antigen and Anti-Dengue Virus IgM Antibody , 2014, PLoS Neglected Tropical Diseases.
[50] R. Russell,et al. The elusive function of the hepatitis C virus p7 protein , 2014, Virology.
[51] S. Halstead,et al. Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. , 2014, Human pathology.
[52] R. Christofferson,et al. Infection with dengue-2 virus alters proteins in naturally expectorated saliva of Aedes aegypti mosquitoes , 2014, Parasites & Vectors.
[53] Yee‐Shin Lin,et al. Protection against Dengue Virus Infection in Mice by Administration of Antibodies against Modified Nonstructural Protein 1 , 2014, PloS one.
[54] A. Sette,et al. T-Cell Immunity to Infection with Dengue Virus in Humans , 2014, Front. Immunol..
[55] D. Fremont,et al. Structural basis of Flavivirus NS1 assembly and antibody recognition , 2014, Proceedings of the National Academy of Sciences.
[56] G. Skiniotis,et al. Flavivirus NS1 Structures Reveal Surfaces for Associations with Membranes and the Immune System , 2014, Science.
[57] A. Adalja,et al. An estimate of the global health care and lost productivity costs of dengue. , 2014, Vector borne and zoonotic diseases.
[58] A. Falconar. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins , 2014, Archives of Virology.
[59] Gathsaurie Neelika Malavige,et al. T cell responses in dengue viral infections. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[60] E. Fikrig,et al. Mosquito Saliva Serine Protease Enhances Dissemination of Dengue Virus into the Mammalian Host , 2013, Journal of Virology.
[61] Yee‐Shin Lin,et al. Anti–Dengue Virus Nonstructural Protein 1 Antibodies Cause NO-Mediated Endothelial Cell Apoptosis via Ceramide-Regulated Glycogen Synthase Kinase-3β and NF-κB Activation , 2013, The Journal of Immunology.
[62] John A. Taylor,et al. Rotavirus NSP4 Triggers Secretion of Proinflammatory Cytokines from Macrophages via Toll-Like Receptor 2 , 2013, Journal of Virology.
[63] Gathsaurie Neelika Malavige,et al. Serum IL-10 as a marker of severe dengue infection , 2013, BMC Infectious Diseases.
[64] Juan Wang,et al. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice. , 2013, Molecular immunology.
[65] M. Ng,et al. Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage , 2013, eLife.
[66] John S. Brownstein,et al. The global distribution and burden of dengue , 2013, Nature.
[67] D. Fremont,et al. Evidence for a Genetic and Physical Interaction between Nonstructural Proteins NS1 and NS4B That Modulates Replication of West Nile Virus , 2012, Journal of Virology.
[68] B. Hankamer,et al. Structure of the dengue virus glycoprotein non-structural protein 1 by electron microscopy and single-particle analysis. , 2012, The Journal of general virology.
[69] G. Gervasi,et al. Nonstructural protein NS1 immunodominant epitope detected specifically in dengue virus infected material by a SELDI‐TOF/MS based assay , 2012, Journal of medical virology.
[70] Ronald J. Moore,et al. Dengue Virus Infection Perturbs Lipid Homeostasis in Infected Mosquito Cells , 2012, PLoS pathogens.
[71] Luís Carlos de Souza Ferreira,et al. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. , 2012, Vaccine.
[72] John A. Taylor,et al. Rotavirus NSP4 is secreted from infected cells as an oligomeric lipoprotein and binds to glycosaminoglycans on the surface of non-infected cells , 2011, Virology Journal.
[73] Yee‐Shin Lin,et al. Dengue Virus-Induced Autoantibodies Bind to Plasminogen and Enhance Its Activation , 2011, The Journal of Immunology.
[74] B. Guy,et al. From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. , 2011, Vaccine.
[75] Cameron P. Simmons,et al. Kinetics of Viremia and NS1 Antigenemia Are Shaped by Immune Status and Virus Serotype in Adults with Dengue , 2011, PLoS neglected tropical diseases.
[76] J. Farrar,et al. Dextran Fractional Clearance Studies in Acute Dengue Infection , 2011, PLoS neglected tropical diseases.
[77] M. Diamond,et al. Binding of Flavivirus Nonstructural Protein NS1 to C4b Binding Protein Modulates Complement Activation , 2011, The Journal of Immunology.
[78] A. Falconar,et al. The NS1 Glycoprotein Can Generate Dramatic Antibody-Enhanced Dengue Viral Replication in Normal Out-Bred Mice Resulting in Lethal Multi-Organ Disease , 2011, PloS one.
[79] S. Sekaran,et al. The Diagnostic Sensitivity of Dengue Rapid Test Assays Is Significantly Enhanced by Using a Combined Antigen and Antibody Testing Approach , 2011, PLoS neglected tropical diseases.
[80] M. Diamond,et al. N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement. , 2011, Virology.
[81] A. Rothman,et al. Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection. , 2011, The Journal of infectious diseases.
[82] Yee‐Shin Lin,et al. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis , 2011, Experimental biology and medicine.
[83] J. d'Alayer,et al. Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein , 2011, Proceedings of the National Academy of Sciences.
[84] K. Ikuta,et al. Highly conserved region 141‒168 of the NS1 protein is a new common epitope region of dengue virus. , 2011, Japanese journal of infectious diseases.
[85] J. Ousingsawat,et al. Rotavirus toxin NSP4 induces diarrhea by activation of TMEM16A and inhibition of Na+ absorption , 2011, Pflügers Archiv - European Journal of Physiology.
[86] J. Farrar,et al. Kinetics of Plasma Viremia and Soluble Nonstructural Protein 1 Concentrations in Dengue: Differential Effects According to Serotype and Immune Status , 2011, The Journal of infectious diseases.
[87] T. Gonda,et al. PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models , 2011, British Journal of Cancer.
[88] S. Yuan,et al. Regulation of Endothelial Barrier Function , 2011 .
[89] F. Zunino,et al. SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis , 2011, Clinical Cancer Research.
[90] I. Liu,et al. Molecular Mimicry of Human Endothelial Cell Antigen by Autoantibodies to Nonstructural Protein 1 of Dengue Virus* , 2011, The Journal of Biological Chemistry.
[91] N. Heaton,et al. Dengue virus-induced autophagy regulates lipid metabolism. , 2010, Cell host & microbe.
[92] C. Chipot,et al. NMR Structure and Ion Channel Activity of the p7 Protein from Hepatitis C Virus* , 2010, The Journal of Biological Chemistry.
[93] M. Diamond,et al. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1 , 2010, The Journal of experimental medicine.
[94] Yue Chen,et al. Comprehensive mapping of immunodominant and conserved serotype- and group-specific B-cell epitopes of nonstructural protein 1 from dengue virus type 1. , 2010, Virology.
[95] Tyler R. Prestwood,et al. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. , 2010, Cell host & microbe.
[96] M. Diamond,et al. Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification , 2010, PLoS pathogens.
[97] B. Wills,et al. Systemic vascular leakage associated with dengue infections - the clinical perspective. , 2010, Current topics in microbiology and immunology.
[98] Yee‐Shin Lin,et al. Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation. , 2009, Molecular immunology.
[99] U. Braga-Neto,et al. Alternative Complement Pathway Deregulation Is Correlated with Dengue Severity , 2009, PloS one.
[100] R. Dwek,et al. The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy , 2009, Proceedings of the National Academy of Sciences.
[101] Yee‐Shin Lin,et al. Deletion of the C-Terminal Region of Dengue Virus Nonstructural Protein 1 (NS1) Abolishes Anti-NS1-Mediated Platelet Dysfunction and Bleeding Tendency1 , 2009, The Journal of Immunology.
[102] Ralf Bartenschlager,et al. Composition and Three-Dimensional Architecture of the Dengue Virus Replication and Assembly Sites , 2009, Cell Host & Microbe.
[103] S. Kashiwagi,et al. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[104] T. Kinoshita,et al. Association of dengue virus NS1 protein with lipid rafts. , 2008, The Journal of general virology.
[105] Yee‐Shin Lin,et al. Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model , 2008, Laboratory Investigation.
[106] R. Lanciotti,et al. Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007 , 2008, Emerging infectious diseases.
[107] E. Harris,et al. Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. , 2008, Virology.
[108] S. Higgs,et al. The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[109] Yee‐Shin Lin,et al. C-terminal region of dengue virus nonstructural protein 1 is involved in endothelial cell cross-reactivity via molecular mimicry , 2008 .
[110] T. Solomon,et al. Pathogenic flaviviruses , 2008, The Lancet.
[111] C. King,et al. Antiplatelet autoantibodies elicited by dengue virus non‐structural protein 1 cause thrombocytopenia and mortality in mice , 2007, Journal of thrombosis and haemostasis : JTH.
[112] M. Diamond,et al. Secreted NS1 of Dengue Virus Attaches to the Surface of Cells via Interactions with Heparan Sulfate and Chondroitin Sulfate E , 2007, PLoS pathogens.
[113] Sheldon Weinbaum,et al. The structure and function of the endothelial glycocalyx layer. , 2007, Annual review of biomedical engineering.
[114] E. Harris,et al. Dengue virus infects macrophages and dendritic cells in a mouse model of infection. , 2007, The Journal of infectious diseases.
[115] Dick W. Slaaf,et al. The endothelial glycocalyx: composition, functions, and visualization , 2007, Pflügers Archiv - European Journal of Physiology.
[116] M. Guzmán,et al. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever‐dengue shock syndrome (DHF/DSS) , 2007, Immunology and cell biology.
[117] S. Burgess,et al. Evidence for the Formation of a Heptameric Ion Channel Complex by the Hepatitis C Virus P7 Protein in Vitro* , 2006, Journal of Biological Chemistry.
[118] H. Schnittler,et al. Structure‐Function Analysis of the Soluble Glycoprotein, sGP, of Ebola Virus , 2006, Chembiochem : a European journal of chemical biology.
[119] R. Césaire,et al. Evaluation of an Enzyme Immunoassay for Detection of Dengue Virus NS1 Antigen in Human Serum , 2006, Clinical and Vaccine Immunology.
[120] K. Yuen,et al. Serotype 1-Specific Monoclonal Antibody-Based Antigen Capture Immunoassay for Detection of Circulating Nonstructural Protein NS1: Implications for Early Diagnosis and Serotyping of Dengue Virus Infections , 2006, Journal of Clinical Microbiology.
[121] M. Blettner,et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. , 2006, The Journal of infectious diseases.
[122] Trai-Ming Yeh,et al. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. , 2006, The American journal of tropical medicine and hygiene.
[123] A. Malik,et al. Signaling mechanisms regulating endothelial permeability. , 2006, Physiological reviews.
[124] Yee‐Shin Lin,et al. Expression of Cytokine, Chemokine, and Adhesion Molecules during Endothelial Cell Activation Induced by Antibodies against Dengue Virus Nonstructural Protein 11 , 2005, The Journal of Immunology.
[125] M. Miles,et al. Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein , 2005, Archives of Virology.
[126] M. Crabtree,et al. Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: Construction and characterization of mutant viruses , 2005, Archives of Virology.
[127] N. M. Dung,et al. Size and charge characteristics of the protein leak in dengue shock syndrome. , 2004, The Journal of infectious diseases.
[128] V. Volchkov,et al. Ectodomain shedding of the glycoprotein GP of Ebola virus , 2004, The EMBO journal.
[129] Elisabetta Dejana,et al. Endothelial cell–cell junctions: happy together , 2004, Nature Reviews Molecular Cell Biology.
[130] J. V. D. van der Meer,et al. Cytokine patterns during dengue shock syndrome. , 2003, European cytokine network.
[131] Yee‐Shin Lin,et al. Antibodies from dengue patient sera cross‐react with endothelial cells and induce damage , 2003, Journal of medical virology.
[132] A. Sanchez,et al. Covalent Modifications of the Ebola Virus Glycoprotein , 2002, Journal of Virology.
[133] A. Nisalak,et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. , 2002, The Journal of infectious diseases.
[134] Yee‐Shin Lin,et al. Endothelial Cell Apoptosis Induced by Antibodies Against Dengue Virus Nonstructural Protein 1 Via Production of Nitric Oxide , 2002, The Journal of Immunology.
[135] Robert Anderson,et al. Dengue Virus Selectively Induces Human Mast Cell Chemokine Production , 2002, Journal of Virology.
[136] Ting-Hsiang Lin,et al. Potential Application of Nonstructural Protein NS1 Serotype-Specific Immunoglobulin G Enzyme-Linked Immunosorbent Assay in the Seroepidemiologic Study of Dengue Virus Infection: Correlation of Results with Those of the Plaque Reduction Neutralization Test , 2002, Journal of Clinical Microbiology.
[137] Susana Vázquez,et al. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. , 2002, Revista panamericana de salud publica = Pan American journal of public health.
[138] V. Deubel,et al. Enzyme-Linked Immunosorbent Assay Specific to Dengue Virus Type 1 Nonstructural Protein NS1 Reveals Circulation of the Antigen in the Blood during the Acute Phase of Disease in Patients Experiencing Primary or Secondary Infections , 2002, Journal of Clinical Microbiology.
[139] S. Dudek,et al. Cytoskeletal regulation of pulmonary vascular permeability. , 2001, Journal of applied physiology.
[140] Shoichiro Tsukita,et al. Multifunctional strands in tight junctions , 2001, Nature Reviews Molecular Cell Biology.
[141] E. Azeredo,et al. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. , 2001, Immunobiology.
[142] Ting-Hsiang Lin,et al. Dengue NS1‐specific antibody responses: Isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever , 2000, Journal of medical virology.
[143] M. Guzmán,et al. Human Dengue Antibodies against Structural and Nonstructural Proteins , 2000, Clinical Diagnostic Laboratory Immunology.
[144] P. Young,et al. An Antigen Capture Enzyme-Linked Immunosorbent Assay Reveals High Levels of the Dengue Virus Protein NS1 in the Sera of Infected Patients , 2000, Journal of Clinical Microbiology.
[145] J. Lepault,et al. Dengue Virus Type 1 Nonstructural Glycoprotein NS1 Is Secreted from Mammalian Cells as a Soluble Hexamer in a Glycosylation-Dependent Fashion , 1999, Journal of Virology.
[146] C. Rice,et al. Genetic Interaction of Flavivirus Nonstructural Proteins NS1 and NS4A as a Determinant of Replicase Function , 1999, Journal of Virology.
[147] Ying-Chang Wu,et al. Antibody responses to an immunodominant nonstructural 1 synthetic peptide in patients with dengue fever and dengue hemorrhagic fever , 1999, Journal of medical virology.
[148] Processing of the Ebola virus glycoprotein. , 1999, Current topics in microbiology and immunology.
[149] C. Rice,et al. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication , 1997, Journal of virology.
[150] A. Falconar,et al. The dengue virus nonstructural-1 protein (NS1) generatesantibodies to common epitopes on human blood clotting,integrin/adhesin proteins and binds to humanendothelial cells: potential implications in haemorrhagic fever pathogenesis , 1997, Archives of Virology.
[151] C. Rice,et al. Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. , 1996, Virology.
[152] P. Young,et al. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. , 1996, Virology.
[153] M. Sinniah,et al. Augmented inflammatory cytokines in primary dengue infection progressing to shock. , 1995, Singapore medical journal.
[154] P. J. Wright,et al. Glycosylation mutants of dengue virus NS1 protein. , 1994, The Journal of general virology.
[155] A. Nisalak,et al. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. , 1994, Archives of virology. Supplementum.
[156] F. Ennis,et al. Cytotoxic T lymphocytes in dengue virus infection. , 1994, Current topics in microbiology and immunology.
[157] S. Sirinavin,et al. Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. , 1991, The American journal of tropical medicine and hygiene.
[158] G. Kuno,et al. Study of anti‐dengue NS1 antibody by Western blot , 1990, Journal of medical virology.
[159] J. Schlesinger,et al. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis , 1990, Journal of virology.
[160] C. Rice,et al. Flavivirus genome organization, expression, and replication. , 1990, Annual review of microbiology.
[161] C. Mandl,et al. Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses. , 1989, Virology.
[162] P. Mason. Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells , 1989, Virology.
[163] A. Nisalak,et al. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. , 1989, The American journal of tropical medicine and hygiene.
[164] J. Schlesinger,et al. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. , 1988, The Journal of general virology.
[165] J. Schlesinger,et al. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. , 1987, The Journal of general virology.
[166] S. Halstead,et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. , 1984, American journal of epidemiology.
[167] T. Chirachariyavej,et al. Electron microscopic study of the vascular endothelial cell in dengue hemorrhagic fever. , 1980, The Southeast Asian journal of tropical medicine and public health.
[168] S. Halstead. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. , 1979, The Journal of infectious diseases.
[169] SB Halstead,et al. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody , 1977, The Journal of experimental medicine.
[170] M. Tuchinda,et al. Histamine content in 24-hour urine in patients with dengue haemorrhagic fever. , 1977, The Southeast Asian journal of tropical medicine and public health.
[171] S. Halstead,et al. Human antibody to dengue soluble complement-fixing (SCF) antigens. , 1973, Journal of immunology.
[172] D. L. Harris,et al. Partial purification and characterization of a dengue virus soluble complement-fixing antigen. , 1970, Journal of immunology.
[173] W. Brandt,et al. Molecular size and charge relationships of the soluble complement-fixing antigens of dengue viruses. , 1970, Virology.
[174] P. Moura,et al. Detection of Circulant Tumor Necrosis Factor-α , Soluble Tumor Necrosis Factor p 75 and Interferon-γ in Brazilian Patients with Dengue Fever and Dengue Hemorrhagic Fever , 2022 .
[175] A. Chakravarti,et al. Circulating levels of tumour necrosis factor-α & interferon-γ in patients with dengue & dengue haemorrhagic fever during an outbreak , 2022 .